Drug Discontinuations

HPS Pharmacies wish to give notice that Pfizer have discontinued the following parenteral antibiotic products:

Product ARTG
Cefazolin Sodium Hospira 1g 56374
Cefepime DBL 1g 161397
Cefepime DBL 2g 161412
Cefoxitin Sodium Hospira 1g 50310
Ceftazidime Hospira 1g 120543
Ceftazidime Hospira 2g 177030
Ceftriaxone Sodium Hospira 1g 167648
Ceftriaxone Sodium Hospira 2g 167651
Meropenem DBL 1g 161447
Meropenem DBL 500mg 161446
Piperacillin & Tazobactam DBL 4g/0.5 128752

None of the above products are contracted by HPS, so there should be no immediate impact on sites.

The discontinuation of these items will decrease competition in the market and reduce the market’s ability to respond to medication shortages. HPS will continue to work with suppliers to ensure a structured and well-stocked supply chain.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Pfizer on 1800 629 921 or your pharmacist at HPS Pharmacies.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates